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Development of cardiovascular disease (CVD) remains a public health concern for young-to-middle-
aged adults, now exacerbated by the increasing prevalence of obesity and sedentary lifestyles. 
Cardiorespiratory fitness (CRF) improves the reclassification of short-term (10-year) CVD risk, but 
has not been uniformly defined across studies. This study evaluated cross-sectional differences in 
short-term and lifetime CVD risk scores, across both absolute metabolic equivalent (MET),  sex- and 
age-standardised CRF categories in 805 healthy apparently healthy young-to-middle aged adults 
(68% male; 47.4 ± 7.2 years). CVD risk factors were evaluated, and estimated cardiorespiratory 
fitness (CRF) measurements (METS and peak VO2) were derived from a submaximal Bruce treadmill 
test. CRF measures also included post-exercise heart rate recovery (HRR) data. Consistent trends 
showing more favorable risk factor profiles and lower short-term CVD (QRISK2), and CVD mortality 
(SCORE) scores, associated with higher levels of CRF were evident in both sexes. Lifetime CVD risk 
(Q-Lifetime) was highest in the lowest CRF categories. Peak VO2 and HRR following submaximal 
exercise testing contributed to the variability in short-term and lifetime CVD risk. Global CVD risk 
predictions were examined across different contemporary CRF classifications with inconsistent 
findings. Recommended absolute MET and sex- and age-standardised CRF categories were 
significantly associated with both short-term and lifetime risk of CVD outcomes. However, compared 
to internationally-derived normative CRF standards, cohort-specific CRF categories resulted in 
markedly different proportion of individuals classified in the “poor” CRF category at higher CVD risk.   
 





Introduction    
Physical activity habits and notably cardiorespiratory fitness (CRF) are important and increasingly 
recognised CVD risk factors, but do not contribute directly to most current global CVD risk prediction 
models used in clinical practice. There is growing interest and evidence to support the implementation 
of a CRF measure (directly-determined or estimated peak VO2, or its metabolic equivalents (METS)), 
into CVD risk estimation (1,2). In the large UK Biobank study (3), significant increases in CVD risk 
with decreasing physical activity were only evident in those with the lowest CRF (7.12±1.5 METS). 
This study further emphasised the relevance of reducing CVD or mortality outcomes among 
individuals who exhibit a ‘low fitness profile’ (i.e. physically inactive plus low CRF). 
 
Ross et al. (1) provided the scientific justification for CRF as an independent CVD risk factor and 
clinical vital sign. Notably, CRF significantly improves the reclassification of risk for short-term CVD 
risk. A progressive and dose-dependent reduction in short-term CVD risk has typically been observed 
with cohort stratification into CRF categories. Accordingly, Kokkinos et al (4) cited several studies that 
have reported that fitter individuals have as much as an 80% reduction in CVD risk compared with 
the least fit individuals, regardless of age, sex, body composition, or other cardiovascular risk factors. 
CRF has been reported to be a characteristic of the metabolically healthy but obese phenotype (5), 
plus low fitness in mid-life has been associated with likelihood of metabolic syndrome (6) and with 
higher lifetime risk for CVD death in a well-characterized cohort with long-term follow-up (7). These 
findings, reinforce the need to assess, monitor and improve CRF and associated surrogate fitness 
measures, such as post-exercise heart rate recovery (HRR), within younger adults to encourage 
positive future health outcomes.  
 
The CVD risk associated with different levels of CRF has varied considerably, even within 
contemporary cohort studies. This is likely related to participant differences and the methodologies 
used to measure and subsequently categorise CRF (typically based on tertile-, quartile- or quintile-
based categories of directly determined or mostly estimated peak VO2/METs) within the prospective 
cohorts. To ameliorate these methodological limitations, standardised methods to uniformly define 
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CRF categories and more accurately quantify the impact of CRF on CVD risk have been advocated 
(1). Several investigators have proposed a sex- and age-adjusted analytical approach to CRF 
categorization (4), (using either peak VO2 expressed in millilitres per kilogram per minute, or METs) 
and/or the utilisation of comprehensive published normative datasets for CRF. Furthermore, low CRF 
combined with poor HRR following exercise testing has also been independently associated with 
increased all-cause and cardiovascular mortality (8). Despite this, simple surrogate measures of 
cardiac autonomic function, such as post-exercise HRR, are not considered in most global CVD risk 
scores, or routinely applied in clinical practice. 
 
UK clinical practice is now routinely adopting the QRISK prediction model, a UK-specific and validated 
predictor of 10-year CVD risk in representative cohorts (9), but European alternative risk algorithms 
(SCORE) are also advised (10).  A major change in the most recent Joint British Society (JBS) 
guidelines on CVD prevention was the recommendation that CVD risk estimation based not only on 
short-term (10-year) risk, but also consider lifetime risk (11). Consideration of a lifetime risk approach, 
particularly within younger adults, may further support appropriate CVD risk 
stratification/management and lifestyle changes. The QRISK lifetime risk model uses a competing 
risks analysis, producing both summary CVD risk, up to 95 years of age, and showing the cumulative 
risk of a CVD event (12). Likewise, the JBS3 CVD risk algorithm provides CVD event-free survival, 
together with 10-year risk scores. Few cross-sectional studies have evaluated associations of CRF 
with lifetime CVD risk. 
 
The purpose of our study was to examine CVD risk factors, both short-term (10-year) and lifetime risk 
of CVD in a cross-sectional study of males and females presenting for routine preventive health 
assessments. We examined associations of CRF and CVD risk using separate fitness classification 
methods, including absolute (METS-based) categories and CRF categories based on internationally 
derived sex- and age-standardised normative data. Further, we evaluated if contemporary CRF 
indices (including predicted peak VO2 and HRR) contributed significant to 10-year and lifetime global 




Materials and Methods 
Participants: A cross-sectional analysis of males and females, free from any cardiovascular and/or 
metabolic conditions, who attended preventive health screening assessments at Nuffield Health in 
Manchester, UK over a 2-year period. These assessments for employed participants were mostly 
funded (in-full, or in-part) through corporate wellness schemes, but a small proportion were self-
funded.  All testing was completed in clinical practice where routine non-gold standard measures were 
used. Prior to the testing, informed consent was obtained from each participant and the study 
conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval 
by the local human research and ethical committee. Each participant completed a comprehensive 
medical and lifestyle questionnaire, which comprised key information for global CVD risk predictions 
(sex, age, smoking status, medical history/medications and family history of myocardial infarction (MI) 
under 60 years). For descriptive purposes, self-reported ratings of physical activity status were sought 
from each participant. Information about weekly frequency and duration of light (<3METS), moderate 
(3-6METS) and vigorous (>6METS) physical activity (PA) was requested with the help of examples 
provided from the updated PA compendium (13).  
 
Test procedures:  
Fasting (12-hour) venous blood samples were obtained from the anticubital fossa using the BD 
Vacutainer® system (New Jersey, USA). For the purpose of CVD risk scores, fasting blood glucose 
(FBG) and lipid profiles including total cholesterol (TC), low-density lipoprotein (LDL-c), high-density 
lipoprotein (HDL-c) and triglyceride (TG) levels were analysed using a point of care Piccolo analyser 
(Abaxis, USA). Resting blood pressure (BP) was measured using a manual sphygmomanometer and 
stethoscope. A second measurement was taken if a blood pressure (BP) >140 mmHg systolic or >90 
mmHg diastolic was recorded (14). 
 
Body mass was measured to the nearest 0.1kg using digital scales (Marsden, UK) and stature 
measured to the nearest 0.1cm using a stadiometer (Seca, Hamburg, Germany), enabling 
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subsequent calculation of BMI. Body fat content (BF%) was determined using the BodyStat 1500 
whole-body bioelectrical impedance analyser (BodyStat Limited, UK), which minimised the inter-tester 
variability associated with other measures of BF%. Waist circumference (WC) was measured at the 
midway point between the lowest rib and iliac crest, and waist-to-hip ratio (WHR) was calculated by 
dividing WC by the hip circumference measured at the level of the greater trochanter (15). In addition, 
waist-to-height ratio (WHtR) was calculated by WC divided by height (16). 
 
Prior to the exercise test, resting heart rate (RHR) was determined by supine 12-lead 
electrocardiography (ECG; Marquette CASE System, GE Healthcare, UK). A submaximal Bruce 
treadmill test was performed (90 ± 5% and 89 ± 3% of age-predicted maximum heart rate (APMHR), 
in males and females respectively). Any participants that displayed abnormal ECG responses during 
and/or post exercise were excluded from the study. Due to the submaximal nature of the test and no 
respiratory gas analysis available in the clinic for objective assessment of oxygen consumption, total 
treadmill time was recorded (17,18). Validated prediction equations for the Bruce treadmill protocol 
were used to calculate  peak VO2  in males (19) and females (20), which were also converted into 
METS [VO2 peak divided by 3.5] for CRF categorisation purposes. Once a target HR of 85-90% APMHR 
was achieved, participants adopted a supine position and HRR data was collected at one and two 
minutes post-exercise. HRR was recorded as a delta value calculated from the submaximal peak 
exercise HR achieved (∆HRR60 and ∆HRR120).  
 
QRISK2 (21) and JBS3 (22) were calculated to determine 10-year global CVD risk using an online 
calculator that required age, sex, smoking status, family history of MI <60 years, TC, HDL-c, BMI and 
BP. The European Heart SCORE online calculator (23) was used to generate 10-year CVD mortality 
risk, based on the work of Conroy et al. (10). In order to report lifetime CV risk, further online 
calculators were used for Q-Lifetime to determine % risk at 95 years of age (24), and JBS provided a 




Statistical analysis: IBM SPSS Version 24 was used for all analyses (Armonk, NY: IBM Corporation). 
Prior to any statistical analysis, data was checked for normality. Most variables were not normally 
distributed using Kolmogorov-Smirnov tests (P<0.05) but given the sample size adequate power 
existed to avoid performing log-transformations. On visual examination of histograms and stem-and-
leaf plots, there were some outliers at the upper-end but no notable skewness was observed. It was 
deemed not appropriate to remove these data points as it was a true reflection of the distribution in 
this wide age group. All data were reported as mean, standard deviation (SD) and/or 95% confidence 
intervals (CI). Student’s independent t-tests were performed to compare the mean values between 
males and females for age, anthropometric measures, CVD risk factors, CRF measures and CVD risk 
scores. Non-parametric tests were performed to identify the difference of lifestyle characteristics 
including smoking and familial history across both sexes and CRF groups. Effect size estimations 
were noted to identify meaningfulness of difference between males and females, and across CRF 
groups.  
 
For the identification of individuals in the lower CRF groups and implicitly at higher CVD risk, three 
distinct methods were adopted to classify CRF, a) absolute MET-based categories; b) tertiles of 
estimated peak VO2, based on the cohort distribution; c) categories of CRF based on internationally 
derived sex- and age-standardised thresholds. The 3 methods used to categorise the CRF results 
are outlined in detail in the supplementary files.   
 
 
Separate unadjusted analysis of variance (ANOVA) models with Bonferroni post-hoc calculations 
were performed on male and females to determine differences in age, anthropometric measures, CVD 
risk factors and HRR across the CRF groups. Models were subsequently adjusted for age and 
smoking status. Within ANOVA models, the CVD risk scores were not adjusted as age and smoking 
status were already accounted for in the risk estimations. To evaluate the CRF and other predictors 
of both short-term and lifetime CVD risk in males and females, backward stepwise linear regression 
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models were run for each CVD risk score. Initially, the regression models were adjusted for age to 
highlight the contribution of this major risk factor (Model1). As age is already accounted for in the CVD 
risk algorithms, each model was also run without age-adjustment (Model2). The independent variables 
entered into the regression models included both CRF predictors (predicted VO2 peak and ΔHRR60), 
and anthropometric variables (BF% and WC). Given, potential collinearity, and given BMI is included 
in all the algorithms for CVD risk a final regression model was run without body fat content. Model1 
and model2 both incorporate the standard predicted peak VO2 and ΔHRR60 as the fitness predictors. 
Model1 was age-adjusted, whereas model2 was not age-adjusted due to the inclusion of “age” as a 
factor in the prediction algorithms. Statistical significance was set at P<0.05. 
 
Results  
Physiological and anthropometric characteristics of the 805 participants (551 males; 254 females) 
are presented in Table 3. Males displayed significantly higher values for most anthropometric 
measures. BMI distribution for normal-weight, overweight and obesity differed between males 
(28.1%, 49.5% and 22.3% respectively) and females (57.9%, 27.6% and 13.8% respectively). Males 
had higher values for standard CVD risk factors (except HDL-c). Males had significantly higher 10-
year risk of CVD events (+3.6% QRISK2) and risk of hard CVD events (+1.2% SCORE) compared 
to females. Longer-term CVD risk estimations also showed males had significantly higher Q-lifetime 
CVD risk (+13.5%) and lower JBS3 survival age (-4.6 years). JBS3 estimated a significantly higher 
mean heart age (1.9 years older for females; 6.1 years older for males) compared to chronological 
age. Similar proportions of males and females were current smokers (29.5 % and 28.3% 
respectively), reported familial hypertension, type 2 diabetes and CVD. (Table S1). 
 
Males exhibited significantly lower resting heart rates and longer treadmill exercise time, but there 
were no significant differences in predicted peak VO2 /METS using standard Bruce protocol equations. 
Females displayed more favourable exercise cardiac autonomic function measures, exhibiting similar 




Cardiorespiratory fitness (CRF) Classifications 
As outlined in the supplementary methods section, Table 1 and 2 illustrates the cohort distribution for 
the 3 different methods used to classify CRF. Table 1a shows the CRF results based on the AHA 
MET-based classification (1). The largest proportion of participants (42.6% male, 52.8% female) were 
categorised as exhibiting higher levels of CRF based on these absolute MET groups.  
 
Lifestyle factors across CRF groups 
The distribution of several lifestyle factors were examined across the three absolute MET-based 
groups. No significant differences in smoking prevalence or alcohol consumption was evident across 
any of the CRF classifications in males and females. As expected, there was a significantly higher 
frequency of moderate and vigorous exercise sessions in the higher CRF groups in both males and 
females (P<0.001 and P=0.002 respectively). In both sexes, the higher absolute CRF groups were 
undertaking a mean of 3.8 ± 2.5 moderate and vigorous exercise sessions per week. Typically, higher 
fitness groups were undertaking 3-4 moderate and vigorous weekly exercise sessions. The high CRF 
groups showed clear trends in the reported frequency of vigorous exercise (all P<0.001). The pattern 
was similar across CRFstd and CRFwm groups. 
 
Associations of CRF with CVD risk factors, fatness, and cardiac autonomic function. 
Table 5 provides unadjusted values for CVD risk factors, anthropometric and cardiac autonomic 
function measures across the absolute CRF groups. As expected, there was a significant difference 
in the age profile across the CRF groups in males and females, with younger mean ages in the higher 
CRF groups. This age disparity was more evident in females (η2=0.139) compared to males 
(η2=0.034). Following adjustment for age and smoking status, anthropometric measures of body fat 
content/distribution and cardiac autonomic function following exercise did not differ across CRF 




As expected, all anthropometric/fatness measures reduced with higher CRF levels (BMI, WC, BF%, 
WHR, WHtR), with the largest differences evident between low CRF and high CRF (all P<0.001). 
These differences represented small-to-medium effect sizes in males (η2=0.57-0.90) and females 
(η2=0.09-0.12), following adjustment for age and smoking status (Table S2). Table 6 Similar analyses 
were performed across the CRFstd and CRFwm (Table S3 and S4), showing body fatness measures 
remain significantly different across the groups, but most notably when comparing the low CRFstd 
group with the two higher groups. Effect sizes for CRF were marginally larger in females (η2=0.05-
0.13) than males (η2=0.05-0.08). The age-specific CRFwm groups showed the high fitness group had 
lower levels of fatness (Table S4), however this trend was clearer for females.  
 
All post-exercise cardiac autonomic function measures (Table S2) were more favourable with higher 
CRF groups, yet small effect sizes (η2=0.028-0.046). Although still highly significant with medium 
effect sizes, the female associations were slightly weakened for RHR (P=0.009), ΔHRR60 (P=0.008) 
and ΔHRR120 (P=0.003), but possibly because of smaller sample size (n=254). Higher CRF was 
associated with a lower RHR but this was a more meaningful difference across CRF groups in males 
than females (η2=0.122 compared to η2=0.037). In CRFstd and CRFwm analyses, the autonomic 
measures followed the same trend with a lower RHR and quicker HRR at both time-points in the 
higher CRF groups (Table S3 and S4).  
 
Most standard CVD risk factors, except LDL-c, HDL-c and blood glucose concentrations showed 
significant differences between the CRF groups, with the largest difference evident between low CRF 
and high CRF (Table S2-S4).  
 
Global CVD risk scores 
Table 5 highlights the observed trend towards differences in estimated 10-year CVD risk across CRF 
groups in both sexes. These analyses demonstrated higher fitness is associated with lower 10-year 
CVD risk, with small-to-medium effect sizes evident for QRISK2 (unadjusted η2=0.05male, 0.10female). 
Reduced short-term risk of CV mortality (SCORE) with higher fitness was found across the CRF 
11 
 
groups in both sexes. This trend was also observed across CRFstd groups and female CRFwm groups. 
Male CRFwm groups did not present a clear downward trend across the three CRFwm groups with 
moderate CRF group showing lower 10-year risk, which could be explained by a larger moderate CRF 
group. However, there was no trend or notable difference in SCORE across male CRFwm groups. 
Lifetime CVD risk (Q-Lifetime), was lower in the highest CRF categories. However, the trend is less 
distinct between lower CRF groups. There was no difference in JBS3 CVD survival age across the 
CRF groups determined by the different CRF thresholds utilised.  
 
Table 6 provides results from stepwise linear regression to identify the main CRF (and fatness 
predictors) of the selected global CVD risk scores in both males and females. In the age-adjusted 
models, 55% and 57% of the variance in estimated short-term CVD risk (QRISK2 score) was 
explained in males and females respectively. Age and waist circumference were the main predictors 
(P<0.001) with either peak VO2 and/ or ΔHRR60 being included in the model. Within model2, 20% and 
28% of the variance in QRISK2 score was explained by the main predictors, in males and females 
respectively. Amongst CRF variables, post-exercise HRR was the most predictive of QRISK2 in 
females. The outcome was similar for SCORE 10-year mortality risk in both regression models. 
Interestingly, when overall BF% was not included as a predictor variable, WC and CRF measures 
were similarly predictive of short-term CVD. Waist circumference was the strongest predictor of 





Table 1: Distribution of participants across three a) absolute MET-based CRF categories 
and b) pooled CRFwm categories 
Table 2: Distributional tertile CRF cut-points for VO2 peak across 3 age bands in the Nuffield 
cohort 
Table 3: Physiological and anthropometric characteristics for all participants  
Table 4: Submaximal exercise test and cardiac autonomic function results in all participants 
Table 5: CVD risk scores across the CRF groups determined by three classification 
methods in males and females 
 
Table 6: Overall predictors of global short and lifetime CVD risk in healthy, young to middle-
aged male and females. 
 
Supplementary files 
Table S1: Lifestyle characteristics for all participants  
Table S2: Unadjusted CVD risk factors and anthropometric profiles across absolute MET-
based CRF categories 
Table S3: Unadjusted CVD risk factors across sex and age-specific tertiles of CRF (CRFstd) 
Table S4: Unadjusted CVD risk factors across age-standardised normative CRF (CRFwm) 
pooled categories 
Table S5: Overall predictors (standardized Beta coefficient) of global short and lifetime CVD 
risk in healthy, young to middle-aged male and females.
Discussion  
This study shows favourable trends for lower estimated 10-year CVD risk and 10-year CVD 
mortality risk with higher CRF levels in a predominantly low risk cohort of young-to-middle-
aged adults attending a preventive medical assessment. Lifetime risk of CVD was also 
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significantly higher with lower levels of CRF. As expected, less pronounced differences in 
short-term and lifetime CVD risk were evident  across the  sex- and age-specific CRF 
categories compared to the absolute CRF definitions (MET-based thresholds referred to within 
the AHA scientific statement). Further, the CRF categories based on internationally derived 
normative data (CRFwm groups)  showed similar trends for lower 10-year and lifetime CVD risk 
associated with higher CRF fitness.  
 
Our findings are consistent with the HUNT Fitness Study, which provided the largest database 
of directly-measured peak VO2 with standard cardiovascular risk factors and self-reported 
physical activity in healthy women and men across a wide range (26). We also demonstrate 
concordance with prospective cohort studies that have shown associations between CRF and 
CVD event outcomes are graded across the CRF distribution.  The meta-analysis of Kodama 
et al. (28) examined associations of CRF with CVD outcomes within 24 prospective cohort 
studies recruiting over 84,000 participants. Using various methods to quantify 
cardiorespiratory fitness (CRF), the studies collectively reported associations of CRF with 
4485 CHD/CVD index events. The risk of cardiovascular events/ mortality was 15% lower for 
each 1-MET increase in exercise capacity (28). Within a categorical analysis, individuals with 
low CRF (<7.9 METs) had a substantially higher risk of all-cause mortality and CHD/CVD 
compared with those with intermediate and high CRF (7.9-10.8 and ≥10.9 METs, 
respectively). These are consistent with our findings of lower CVD risk across the AHA CRF 
metabolic equivalents (MET) categories for exercise capacity (1). The Kodama meta-analysis 
included only 10 studies employing standardised maximal exercise testing procedures, 
including the Kuopio Ischaemic Heart Disease Risk Factor Study. In that study peak VO2 , 
measured directly with respiratory gas exchange, was predictive of non-fatal and fatal cardiac 
events among a representative randomly selected sample of 1294 healthy men during a 13-
year follow-up (29). Within participants (with various combinations of risk factors), a one-MET 
increment in CRF amounted to an average decrease of 17-29% in non-fatal and 28-51% in 
fatal cardiac events, after adjustment for age. The age-adjusted risk of fatal cardiac events 
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was more than 4.5-fold higher in healthy individuals with a VO2max in the lowest quartile (below 
27.6 ml O2/kg/min; 8 METS) compared to the highest aerobic fitness quartile (VO2max above 
37.1 ml O2/kg/min; 10.6 METS). 
 
The CVD risk associated with different CRF classifications has varied considerably between 
previously published prospective cohort studies. This is likely related to participant differences 
and the methodologies used to measure and classify CRF (typically quartile- or quintile-based 
categories of peak VO2/ METs) within the cohorts. A recent report from the large UK Biobank 
study, utilised age- and sex-specific tertiles of peak VO2 derived from submaximal cycle 
exercise testing to examine prospective associations with CVD outcomes (3). The association 
between physical activity and mortality was stronger among those in the lowest tertile of CRF 
(HR:1.13 [1.02–1.26]) than those in the highest (HR:1.03 [0.91–1.16]). The pattern for physical 
activity and CRF with CVD events was reported by the authors to be comparable.  
 
We have explored standardised methods to uniformly examine CRF categories. In particular, 
we have incorporated normative reference data from several representative reports to more 
accurately quantify the impact of CRF on predicted short and long-term CVD. The differences 
in these primary studies and there normative results have been described in detail elsewhere 
(1,26,27). We applied a weighted mean approach, combining the sex- and age-specific 
quintiles (20% cut-points) from these 3 large-scale, representative US, and two northern 
European cross-sectional epidemiological studies all employing maximal treadmill testing and 
incorporating respiratory gas analysis. CRF categories based on this normative data showed 
favourable trends to short-term and lifetime CVD risk reduction with higher fitness in all adults 
in the present cohort. Few prospective studies have examined associations of CRF with 
lifetime CVD risk.  In an analysis from the Aerobic Center Longitudinal study (ACLS), low CRF 
fitness, obtained from a single measurement of exercise capacity, was associated with marked 




We examined the predictive role of CRF variables on estimated short-term and lifetime CVD 
risk. Our multivariate regression analyses indicated that CRF and body fatness variables, 
especially waist circumference, were significant predictors of both short- and longer-term CVD 
risk in both males and females. Whilst, age and waist circumference were the strongest 
independent predictors of short and lifetime CVD risk, either peak VO2  and/or HRR were 
retained within the final regression models. Amongst CRF variables, post-exercise HRR was 
the most predictive of QRISK2 in females. It is increasingly appreciated that CRF and 
measures of cardiac autonomic function are interlinked and associated with CVD. Mora and 
colleagues (27) reported that the routine inclusion of both CRF and post-exercise heart rate 
recovery (HRR) measurements enhanced risk prediction using the Framingham 10-year risk 
score in asymptomatic middle-aged adults in the United States. These findings provide further 
support for the potential value of cardiac autonomic function measurements within 
preventative health settings. A recent meta-analysis (30) confirmed associations of post-
exercise heart rate recovery with cardiovascular events in middle-aged adults. Within five 
prospective cohort studies examining cardiovascular events, enrolling 1061 cases from 
34 267 participants, the pooled hazard ratios associated with attenuated HRR (referent) 
compared to rapid HRR after exercise testing was 1.69 (95% CI 1.05-2.71) for cardiovascular 
events. Supplementary analyses indicated that the associations of attenuated HRR and 
increased risk of fatal cardiovascular events were independent of traditional CVD risk factors. 
Our study provides complimentary, albeit indirect evidence that CVD risk assessment /CRF 
assessments should consider the inclusion of a simple measure of post-exercise cardiac 
autonomic function (HRR) to enhance risk predictions in apparently healthy, young-to-middle-
aged adults. The inclusion of CRF, determined by METS from maximal exercise, enhances 
Framingham risk predictions (31), and improves short and long-term risk for CVD mortality 
when added to traditional risk factors (2). To our knowledge, Mora and co-workers are the 
only others to have investigated the inclusion of a HRR measure with global 10-year risk (31). 
In over 6 000 asymptomatic individuals with Framingham risk scores <20%, they reported an 
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enhanced CVD risk prediction with the addition of ΔHRR120 and METS to Framingham 
equations. 
 
Our findings support recommendations to reduce global CVD risk in apparently healthy young-
to-middle-aged adults, a focus should be initially placed on lifestyle factors within young- and 
middle-aged adults exhibiting poor CRF. This involves improving peak CRF and 
parasympathetic activity by weight loss and/or regular moderate-to-vigorous exercise training 
interventions (32). We also supports the recommendations for  preventive health centres to 
routinely measure and classify both CRF and HRR as clinical vital signs in cardiovascular 
health (33). However, our findings provide evidence of inconsistencies in the classification of 
the “low fitness phenotype” within younger- and middle-aged adults. To illustrate this issue, 
we have presented analyses using  several different  methods of classifying CRF, including in 
absolute exercise capacity values recommended by an expert consensus (1) and CRF sex- 
and age-specific cut-points based on distributional tertiles within our cohort, and CRF 
categories based on normative reference data from three representative studies.  
 
Within our cohort, it appears that using AHA recommended MET-based thresholds for 
exercise capacity (Table 1) leads to a disproportionately lower number of participants 
assigned to the “low CRF phenotype” compared to either cohort specific,. or normative CRF 
reference data approaches. Our weighted mean CRF cut-points established from studies 
employing “gold-standard “ treadmill cardiopulmonary exercise testing-  were similar in males, 
but slightly lower in females by comparison to the widely applied ACSM CRF classifications 
(14). The ACSM fitness thresholds were devised from the Aerobics Centre Longitudinal Study 
cohort using estimated peak VO2 from the Balke treadmill protocol. They were approximately 
midway between two of the reference norms derived from gold-standard CRF testing methods 
(25,27), but the HUNT norms (26) were evidently higher in both sexes. These were compared 
to cohort-specific cut-points for low, moderate, and high CRF, consistent with epidemiological 
approaches. The differences evident in our CVD findings across the retrospective aerobic 
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fitness categorisations require further consideration and a standardised approach across 
studies would be useful to reduce these inherent limitation and interpretation within the 
literature examining such associations.    
 
Consistent with other reports, the most obvious limitation is the cross-sectional study design 
that, in principle, does not allow causal inferences between peak VO2 and the prevalence of 
unfavorable levels of CVD risk factors and predicted short- and long-term CVD risk.  
Participants were recruited from a preventive health-screening centre primarily recruiting the 
employees of corporate clients and are likely to be more representative of higher 
socioeconomic groups. The QRISK and JBS3 risk algorithms employed for CVD risk 
estimation both include a measure of socioeconomic status. Future studies should employ 
similar methodological approaches to cohorts with a wider socioeconomic demographic. 
Submaximal exercise testing with prediction of peak VO2 was applied in this study, this 
approach certainly has its limitations. However, this methodology for determining CRF has 
been widely applied in prospective and cross-sectional epidemiological studies of short-term 
CVD risk. Submaximal methodologies accommodate most population groups in terms of 
ability to complete the test and to minimise safety concerns associated with maximal exercise 
testing. By comparison, with regard to measures of cardiac autonomic function, submaximal 
testing has actually been favoured to determine HRR as it reduces the interference by 
heightened sympathetic activity associated with maximal exercise testing (34). In addition, 
HRR has been reported to be a reliable measure following submaximal exercise (35). The 
predictive value of CRF may have increased if the testing had been maximal in nature. 
However, most exercise testing performed in non-hospital settings in the UK is submaximal. 
To provide preventive CVD screening to large population groups, it is not always feasible to 
perform expensive, resource intensive, “gold-standard” maximal tests with respiratory gas 
analysis. Surrogate submaximal treadmill exercise tests and perhaps non-exercise models for 




In conclusion, we have reported that predicted peak VO2  and post-exercise heart rate 
recovery (ΔHRR60) derived from submaximal treadmill exercise testing were strong and 
significant predictors of 10-year and lifetime CVD risk (as measured by the QRISK2, SCORE 
and related CVD risk algorithms) within apparently healthy, young-to-middle-aged adults. 
These findings highlight the potential value of routine monitoring of CRF and simple post-
exercise testing HRR measures as important contemporary CVD risk indicators. We have 
shown with relative consistency that CRF groups determined by different classification 
methods are associated with both short-term and lifetime estimates of CVD risk. Yet, the 
proportion of individuals with higher CVD risk based on lower CRF varies considerably with 
the categorization method adopted. This reinforces the importance for a standardized 
approach to CRF categorization in order to support its implementation in future risk 
stratification and clinical practice. 
 
Perspective 
Cardiorespiratory fitness is increasingly recognised as a clinical vital sign and viewed as 
complimentary to the established global CVD risk prediction algorithms applied in primary 
prevention settings.  However, there is a need to adopt more standardised approaches to CRF 
classification for identification of individuals exhibiting “low CRF” and implicitly at higher CVD 
risk. The aim of this study was to examine short-term (10-year) and lifetime risk of CVD using 
establish CVD algorithms (QRISK, European SCORE) associated with CRF; but applying 
different methods to classify CRF (including absolute METS and across levels of estimated 
maximum oxygen uptake (VO2 max) based on cohort distributional cut-points, or internationally 
derived sex- and age-standardised thresholds). As expected, younger and middle-aged 
participants with higher levels of CRF demonstrated significantly lower estimated short and 
lifetime CVD risks compared to their lower fitness counterparts .  However, we highlight that 
using absolute thresholds based on METS leads to a disproportionately fewer participants 
assigned to the lower CRF groups compared to cohort specific or normative reference 
approaches. Accordingly, our findings highlight the inconsistencies evident with different 
19 
 
methodological approaches to CRF classification and reinforce recent recommendations to 
implement more standardised approaches to CRF categorization, to support their wider 
implementation into risk stratification within clinical practice.  
 
Acknowledgements 





1.  Ross R, Blair SN, Arena R, Church TS, Després J, Franklin B, et al. Importance of 
Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a 
Clinical Vital Sign: A Scientific Statement From the American Heart Association. 
Circulation. 2016 Dec 13;134(24):e653 LP-e699.  
2.  Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, et al. 
Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease 
Mortality. Circulation. 2011;123(13):1377–83.  
3.  Celis-Morales CA, Lyall DM, Anderson J, Iliodromiti S, Fan Y, Ntuk UE, et al. The 
association between physical activity and risk of mortality is modulated by grip 
strength and cardiorespiratory fitness: evidence from 498 135 UK-Biobank 
participants. Eur Heart J. 2017 Jul 6;38(2):116–22.  
4.  Kokkinos P, Myers J, Franklin B, Narayan P, Lavie CJ, Faselis C. Cardiorespiratory 
Fitness and Health Outcomes: A Call to Standardize Fitness Categories. Mayo Clin 
Proc. 2018;93(3):333–6.  
5.  Ingle L, Swainson M, Brodie D, Sandercock GR. Characterization of the metabolically 
healthy phenotype in overweight and obese British men. Prev Med (Baltim). 2017 
Jan;94:7–11.  
6.  Ingle L, Mellis M, Brodie D, Sandercock GR. Associations between cardiorespiratory 
fitness and the metabolic syndrome in British men. Heart. 2017 Apr 1;103(7):524–8.  
7.  Berry JD, Willis B, Gupta S, Barlow CE, Lakoski SG, Khera A, et al. Lifetime Risks for 
Cardiovascular Disease Mortality by Cardiorespiratory Fitness Levels Measured at 
Ages 45, 55, and 65 Years in Men. J Am Coll Cardiol. 2011;57(15):1604–10.  
8.  Cole C, Foody J, Blackstone E, Lauer M. Heart Rate Recovery after Submaximal 
Exercise Testing as a Predictor of Mortality in a Cardiovascularly Healthy Cohort. Ann 
Intern Med. 2000 Apr 4;132(7):552–5.  
9.  Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. 
Predicting cardiovascular risk in England and Wales: Prospective derivation and 
21 
 
validation of QRISK2. BMJ. 2008;336(7659):1475–82.  
10.  Conroy R, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. 
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE 
project. Eur Heart J. 2003 Jun 1;24(11):987–1003.  
11.  JBS3 Board. Joint British Societies’ consensus recommendations for the prevention of 
cardiovascular disease ( JBS3). Heart. 2014;100:ii1–ii67.  
12.  Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and 
evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: 
cohort study using QResearch database. 2010;341:c6624.  
13.  Ainsworth B, Haskell W, Whitt M, Irwin M, Swartz A, Strath S, et al. Compendium of 
Physical Activities: an update of activity codes and MET intensities. Med Sci Sports 
Exerc. 2000;32(9):S498–516.  
14.  ACSM. ACSM’s Guidelines to Exercise Testing and Prescription. 8th ed. Baltimore, 
MD: Lippincott Willimas & Wilkins; 2010.  
15.  Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference 
Manual. 2nd ed. Champaign IL.: Human Kinetics; 1991.  
16.  Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than 
waist circumference and BMI for adult cardiometabolic risk factors: systematic review 
and meta-analysis. Obes Rev. 2012;13:275–86.  
17.  Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations 
between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb 
Vasc Biol. 2002 Nov 1;22(11):1869–76.  
18.  Carnethon M, Gidding S, Nehgme R, Sidney S, Jacobs Jr D, Liu K. Cardiorespiratory 
Fitness in Young Adulthood and the Development of Cardiovascular Disease Risk 
Factors. JAMA. 2003 Dec 17;290(23):3092.  
19.  Foster C, Jackson AS, Pollock ML, Taylor MM, Hare J, Sennett SM, et al. Generalized 




20.  Pollock M, Foster C, Schmidt D. Comparative analysis of physiologic responses to 
three different maximal graded exercise test protocols in healthy women. Am Heart J. 
1982;103(3):363–73.  
21.  ClinRisk. QRISK®2-2015 calculator [Internet]. [cited 2016 Nov 13]. Available from: 
http://qrisk.org 
22.  JBS3. JBS3 Risk Calculator [Internet]. [cited 2017 Oct 10]. Available from: 
http://www.jbs3risk.com/ 
23.  European Society of Cardiology. HeartScore® risk calculator [Internet]. [cited 2017 
Oct 10]. Available from: http://www.heartscore.org/en_GB 
24.  ClinRisk. QRISK®-lifetime cardiovascular risk calculator [Internet]. [cited 2017 Oct 
10]. Available from: https://qrisk.org/lifetime/ 
25.  Kaminsky LA, Arena R, Myers J. Reference Standards for Cardiorespiratory Fitness 
Measured With Cardiopulmonary Exercise Testing: Data From the Fitness Registry 
and the Importance of Exercise National Database. Majo Clin Proc. 
2015;90(11):1515–23.  
26.  Loe H, Nes BM, Wisløff U. Predicting VO2peak from Submaximal- and Peak Exercise 
Models: The HUNT 3 Fitness Study, Norway. PLoS One. 2016;11(1):e0144873.  
27.  Edvardsen E, Scient C, Hansen B, Holme I, Dyrstad S, Anderssen S. Reference 
Values for Cardiorespiratory Response and Fitness on the Treadmill in a 20- to 85-
Year-Old Population. Chest. 2013;144(1):241–8.  
28.  Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory 
Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events 
in Healthy Men and Women. JAMA. 2009 May 20;301(19):2024.  
29.  Laukkanen JA, Rauramaa R, Salonen JT, Kurl S. The predictive value of 
cardiorespiratory fitness combined with coronary risk evaluation and the risk of 
cardiovascular and all-cause death. J Intern Med. 2007 Aug 1;262(2):263–72.  
30.  Qiu S, Cai X, Sun Z, Li L, Zuegel M, Steinacker JM, et al. Heart Rate Recovery and 
Risk of Cardiovascular Events and All-Cause Mortality: A Meta-Analysis of 
23 
 
Prospective Cohort Studies. J Am Heart Assoc. 2017 May 9;6(5):e005505.  
31.  Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced risk assessment in 
asymptomatic individuals with exercise testing and Framingham risk scores. 
Circulation. 2005;112(11):1566–72.  
32.  Brinkworth GD, Noakes M, Buckley JD, Clifton PM. Weight loss improves heart rate 
recovery in overweight and obese men with features of the metabolic syndrome. Am 
Heart J. 2006;152(4):693.e1-693.e6.  
33.  Després J-P. Physical Activity, Sedentary Behaviours, and Cardiovascular Health: 
When Will Cardiorespiratory Fitness Become a Vital Sign? Can J Cardiol. 2016 Apr 
1;32(4):505–13.  
34.  Buchheit M, Gindre C. Cardiac parasympathetic regulation: respective associations 
with cardiorespiratory fitness and training load. Am J Physiol Circ Physiol. 2006 
Jul;291(1):H451–8.  
35.  Mellis M, Ingle L, Carroll S. Variability in Heart Rate Recovery Measurements Over 1 
Year in Healthy, Middle-Aged Adults. Int J Sports Med. 2014 Jul 18;35(2):135–8.  
 
